TEL AVIV, Israel, April 26, 2022 /PRNewswire/ — Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Robert A. Gabbay M.D., Ph.D. has joined the company as an advisor. Dr. Gabbay brings far-reaching experience implementing innovative models of care for people affected by diabetes and will help Sweetch further its global adoption.
Read more here.
![[SaNOtize in Business Wire] SaNOtize’s board appoints Steven Basta as new Chief Executive Officer](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
